New insights into the roles of endolysosomal cathepsins in the pathogenesis of Alzheimer's disease: cathepsin inhibitors as potential therapeutics

A Haque, NL Banik, SK Ray - CNS & Neurological Disorders …, 2008 - ingentaconnect.com
Endolysosomal proteases such as cysteinyl and aspartyl cathepsins play diverse roles in
inflammatory autoimmune diseases, cancers, and neurodegenerative diseases. Cysteinyl …

[HTML][HTML] Pathophysiology of age-related diseases

G Campisi, M Chiappelli, M De Martinis, V Franco… - Immunity & …, 2009 - Springer
A Symposium regarding the Pathophysiology of Successful and Unsuccessful Ageing was
held in Palermo, Italy on 7-8 April 2009. Three lectures from that Symposium by G. Campisi …

A highly effective and stable butyrylcholinesterase inhibitor with multi-faceted neuroprotection and cognition improvement

Q Li, B Xiong, Y Wang, W Lyu, S Xing, Y Chen… - European Journal of …, 2022 - Elsevier
Butyrylcholinesterase (BChE) has been more and more attractive for treating
neurodegenerative diseases, especially Alzheimer's disease (AD). In this study, we …

[HTML][HTML] Photoreceptor neuroprotection in RCS rats via low-dose intravitreal sustained-delivery of fluocinolone acetonide

IV Glybina, A Kennedy, P Ashton… - … & visual science, 2009 - iovs.arvojournals.org
purpose. To study the neuroprotective effects of intravitreal fluocinolone acetonide (FA) in
Royal College of Surgeons (RCS) rats. methods. Five-week-old RCS rats were divided into …

[HTML][HTML] Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for …

Z Stozicka, N Zilka, P Novak, B Kovacech… - Journal of …, 2010 - Springer
Background Numerous epidemiological studies demonstrate that genetic background
modifies the onset and the progression of Alzheimer's disease and related …

Elevated plasma levels of α-1-Anti-Chymotrypsin in age-related cognitive decline and Alzheimer's disease: a potential therapeutic target

E Porcellini, EJ Davis, M Chiappelli… - Current …, 2008 - ingentaconnect.com
α-1-antichymotrypsin (ACT), is an acute phase protein and a protease inhibitor produced by
the liver and brain. ACT is involved in the pathogenesis of Alzheimer's disease (AD), since …

Reduced plasma levels of P-selectin and L-selectin in a pilot study from Alzheimer disease: relationship with neuro-degeneration

MM Corsi, F Licastro, E Porcellini, G Dogliotti… - Biogerontology, 2011 - Springer
Neurodegenerative processes associated with Alzheimer's disease (AD) are accompanied
by reactive astrogliosis and microglia activation and a role for chronic inflammation in the …

Multivariable network associated with cognitive decline and dementia

F Licastro, E Porcellini, M Chiappelli, P Forti… - Neurobiology of …, 2010 - Elsevier
Data mining of a large data base from the population longitudinal study named “The
Conselice Study” has been the focus of the present investigation. Initially, 65 years old or …

Sharing pathogenetic mechanisms between acute myocardial infarction and Alzheimer's disease as shown by partially overlapping of gene variant profiles

F Licastro, M Chiappelli, CM Caldarera… - Journal of …, 2011 - content.iospress.com
Gene variants that promote inflammation and cholesterol metabolism have been associated
with acute myocardial infarction (AMI) and Alzheimer's disease (AD). We investigated a …

[HTML][HTML] Altered glycosylation profile of purified plasma ACT from Alzheimer's disease

M Ianni, M Manerba, G Di Stefano, E Porcellini… - Immunity & …, 2010 - Springer
Background Alzheimer's disease (AD) is one of the most frequent cause of
neurodegenerative disorder in the elderly. Inflammation has been implicated in brain …